PAMP
TNGX icon

Polar Asset Management Partners’s Tango Therapeutics TNGX Stock Holding History

Polar Asset Management Partners’s Portfolio TNGX Stock Details TNGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-56,100
Closed -$287K – 806
2025
Q2 		$287K Buy
+56,100
New +$139K ﹤0.01% 428
2020
Q4 		– Sell
-25,000
Closed -$259K – 910
2020
Q3 		$259K Buy
+25,000
New +$255K ﹤0.01% 507

Other funds holding TNGX

TGI
TRV GP IV Boston, Massachusetts $267M AUM 965.83% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $762M AUM 1,125.36% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Polar Asset Management Partners's TNGX Position: Q3 2025 in Review

Polar Asset Management Partners sold out of Tango Therapeutics (TNGX) in Q3 2025, closing a stake of 56,100 shares — an estimated $287K sold.

Polar Asset Management Partners first reported a position in TNGX in Q3 2020 and held it in 2 quarters. The position peaked at $287K in Q2 2025. 141 funds tracked by Wall St. Rank hold TNGX as of Q3 2025.

  • Polar Asset Management Partners reported no remaining Tango Therapeutics position as of Q3 2025 after selling out during the quarter.
  • Polar Asset Management Partners sold 56,100 Tango Therapeutics shares in Q3 2025, an estimated $287K.
  • Polar Asset Management Partners first reported a position in Tango Therapeutics in Q3 2020 and held it in 2 quarters.
  • Polar Asset Management Partners's Tango Therapeutics position peaked at $287K in Q2 2025.
  • 141 funds tracked by Wall St. Rank held Tango Therapeutics as of Q3 2025.

Based on Polar Asset Management Partners's 13F filing for Q3 2025, filed 14 Nov 2025.